GRACELL BIOTECHNOLOGIES INC's ticker is GRCL and the CUSIP is 38406L103. A total of 46 filers reported holding GRACELL BIOTECHNOLOGIES INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PATHSTONE FAMILY OFFICE, LLC | 49,158 | $141,575 | 0.00% |
| MARSHALL WACE, LLP | 119,489 | $344,128 | 0.00% |
| FRED ALGER MANAGEMENT, LLC | 61,578 | $177,345 | 0.00% |
| BARCLAYS PLC | 311,520 | $898 | 0.00% |
| China Universal Asset Management Co., Ltd. | 1,748 | $5 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 15,861 | $45,680 | 0.00% |
| Eagle Bay Advisors LLC | 210 | $605 | 0.00% |
| JPMORGAN CHASE & CO | 12,838 | $36,973 | 0.00% |
| Renaissance Technologies | 46,600 | $134 | 0.00% |
| ROYAL BANK OF CANADA | 30 | $0 | 0.00% |
| Cubist Systematic Strategies, LLC | 1,407 | $4,052 | 0.00% |
| Point72 Asset Management, L.P. | 31,200 | $89,856 | 0.00% |
| UBS Group AG | 2,312 | $6,659 | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 32,803 | $94,473 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 665 | $1,915 | 0.00% |
| PNC FINANCIAL SERVICES GROUP, INC. | 150 | $432 | 0.00% |
| WELLS FARGO & COMPANY/MN | 6,754 | $19,452 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 43,334 | $124,801 | 0.00% |
| CITIGROUP INC | 846 | $2,436 | 0.00% |
External links
This page lists GRACELL BIOTECHNOLOGIES INC's shareholders in Q3 2023. To view GRACELL BIOTECHNOLOGIES INC's shareholder history, click here.